Group 3
  • Plan
  • Team
  • Partners
  • News & Updates
Contact Us
Contact Us

News & Updates

  • All
  • News
  • Press Release
10/15/22Press Release

SOLVE FSHD Invests Up To US $10 Million in Vita Therapeutics

View Article
10/12/22Press Release

SOLVE FSHD Invests US $1 Million in miRecule to Accelerate Development of Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy

View Article
09/22/22Press Release

SOLVE FSHD Invests US$3 Million in Altay Therapeutics

Learn about AltayPress Release
09/20/22News

SOLVE FSHD Provides Funding to n-Lorem for a Collaboration to Expand Understanding of FSHD2, a Rare Form of Muscular Dystrophy

View Article
06/08/22News

SOLVE FSHD Announces Appointment of Executive Director Dr. Eva Chin and Venture-Philanthropic Funding Structure

View Article
03/11/22Press Release

SOLVE FSHD is supporting the FSHD Clinical Trial Research Network (CTRN) through a donation of $2.8M to the FSHD Canada Foundation

fshd.ca
03/09/22News

SOLVE FSHD Supports the FSHD Canada Foundation in Funding of US$1.2M in Multidisciplinary Biomarker Grants

Press Release
03/09/22News

From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD

View Article
I prefer not to sit in the stands, but to be on the court to solve this disease that is so very close to my heart.
— CHIP WILSON
  • Plan
  • Team
  • Partners
  • News & Updates
  • Contact Us
  • FAQ
© 2022 Solve FSHD
  • Privacy Policy
  • Terms of Service